PROTALIX BIOTHERAPEUTICS INC - COM (PLX)

CUSIP: 74365A101

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class
Equity / COM
Total 13F shares
7,855,174
Share change
-363,501
Total reported value
$3,378,730
Price per share
$0.43
Number of holders
29
Value change
-$204,252
Number of buys
11
Number of sells
11

Quarterly Holders Quick Answers

What is CUSIP 74365A101?
CUSIP 74365A101 identifies PLX - PROTALIX BIOTHERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PROTALIX BIOTHERAPEUTICS INC - COM (PLX) as of Q2 2018

As of 30 Jun 2018, PROTALIX BIOTHERAPEUTICS INC - COM (PLX) was held by 29 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,855,174 shares. The largest 10 holders included Opaleye Management Inc., RENAISSANCE TECHNOLOGIES LLC, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, SG Americas Securities, LLC, BRIDGEWAY CAPITAL MANAGEMENT INC, MACQUARIE GROUP LTD, WELLS FARGO & COMPANY/MN, CITADEL ADVISORS LLC, MEITAV DASH INVESTMENTS LTD, and FEDERATED INVESTORS INC /PA/. This page lists 29 institutional shareholders reporting positions in this security for the Q2 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.